On Air Now

Listen

Listen Live Now » 100.3 FM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
63° Feels Like: 63°
Wind: S 6 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Scattered Thunderstorms 59°

Tomorrow

Thundershowers 85°

Sat Night

Thunderstorms 68°

Alerts

Merck's ragweed pollen allergy drug gets U.S. approval

(Reuters) - The U.S. Food and Drug Administration has approved Merck & Co's pollen allergy drug Ragwitek.

The tablet, which is administered by placing it under the tongue, is to treat the short ragweed pollen induced allergic rhinitis. (http://r.reuters.com/nyg68v)

The approval for Ragwitek comes days after U.S. regulatory approval for Merck's grass pollen allergy drug Grastek.

Merck's Grastek will compete with Stallergenes SA's immunotherapy treatment for five types of grass pollen, which was approved by the FDA earlier this month.

(This story corrects fourth paragraph to say Grastek, not Ragwitek, will compete with Stallergenes' drug)

(Reporting by Shailesh Kuber; Editing by Sriraj Kalluvila)

Comments